Immunogenicity and protective efficacy of Semliki forest virus replicon-based DNA vaccines encoding goatpox virus structural proteins

Virology

Volumn 391, Issue 1, 2009, Pages 33-43

  Zheng, Min ^a,b,c   Jin, Ningyi ^a   Liu, Qi ^b   Huo, Xiaowei ^a   Li, Yang ^a,c   Hu, Bo ^a   Ma, Haili ^a   Zhu, Zhanbo ^a   Cong, Yanzhao ^a   Li, Xiao ^a   Jin, Minglan ^a   Zhu, Guangze ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b Guangxi Center for Animal Disease Control and Prevention   (China)

^c JILIN UNIVERSITY   (China)

Author keywords

Capripoxvirus; DNA vaccine; Goatpox virus; Immune response; Replicon DNA; Semliki forest virus

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; GOATPOX VACCINE; LIVE VACCINE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFICACY; GOAT; HUMORAL IMMUNITY; IMMUNOGENICITY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POXVIRUS INFECTION; PRIORITY JOURNAL; REPLICON; SEMLIKI FOREST ALPHAVIRUS; VACCINATION; VETERINARY MEDICINE; VIRUS VIRULENCE;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY FORMATION; CAPRIPOXVIRUS; CELL PROLIFERATION; GOATS; IMMUNITY, CELLULAR; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; POXVIRIDAE INFECTIONS; SEMLIKI FOREST VIRUS; T-LYMPHOCYTES; VACCINATION; VACCINES, DNA; VIRAL STRUCTURAL PROTEINS; VIRAL VACCINES;

CAPRA HIRCUS; CAPRIPOXVIRUS; GOATPOX VIRUS; MUS; ORTHOPOXVIRUS; SEMLIKI FOREST VIRUS; VACCINIA VIRUS;

EID: 67650729370     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.05.031     Document Type: Article

References (35)

1. Bell E., Shamim M., Whitbeck J.C., Sfyroera G., Lambris J.D., and Isaacs S.N. Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin. Virology 325 (2004) 425-431
2. Bowden T.R., Babiuk S.L., Parkyn G.R., Copps J.S., and Boyle D.B. Capripoxvirus tissue tropism and shedding: a quantitative study in experimentally infected sheep and goats. Virology 371 (2008) 380-393
3. Carn V.M., Timms C.P., Chand P., Black D.N., and Kitching R.P. Protection of goats against capripox using a subunit vaccine. Vet. Rec. 135 (1994) 434-436
4. Davies D.H., McCausland M.M., Valdez C., Huynh D., Hernandez J.E., Mu Y., Hirst S., Villarreal L., Felgner P.L., and Crotty S. Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice. J. Virol. 79 (2005) 11724-11733
5. de Felipe P., Martín V., Cortés M.L., Ryan M., and Izquierdo M. Use of the 2A sequence from foot-and-mouth disease virus in the generation of retroviral vectors for gene therapy. Gene Therapy 6 (1999) 198-208
6. de Paula L., Silva C.L., Carlos D., Matias-Peres C., Sorgi C.A., Soares E.G., Souza P.R., Bladés C.R., Galleti F.C., Bonato V.L., Gonçalves E.D., Silva E.V., and Faccioli L.H. Comparison of different delivery systems of DNA vaccination for the induction of protection against tuberculosis in mice and guinea pigs. Genet. Vaccines Ther. 24 (2007) 2
7. DiCommo D.P., and Bremner R. Rapid, high level protein production using DNA-based Semliki Forest virus vectors. J. Biol. Chem. 273 (1998) 18060-18066
8. Donnelly M.L., Gani D., Flint M., Monaghan S., and Ryan M.D. The cleavage activities of aphthovirus and cardiovirus 2A proteins. J. Gen. Virol. 78 (1997) 13-21
9. Fang M., Cheng H., Dai Z., Bu Z., and Sigal L.J. Immunization with a single extracellular enveloped virus protein produced in bacteria provides partial protection from a lethal orthopoxvirus infection in a natural host. Virology 345 (2006) 231-243
10. Fogg C., Lustig S., Whitbeck J.C., Eisenberg R.J., Cohen G.H., and Moss B. Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions. J. Virol. 78 (2004) 10230-10237
11. Furler S., Paterna J.C., Weibel M., and Bueler H. Recombinant AAV vectors containing the foot and mouth disease virus 2A sequence confer efficient bicistronic gene expression in cultured cells and rat substantia nigra neurons. Gene Ther. 8 (2001) 864-873
12. Galmiche M.C., Goenaga J., Wittek R., and Rindisbacher L. Neutralizing and protective antibodies directed against vaccinia virus envelope antigens. Virology 254 (1999) 71-80
13. Hooper J.W., Custer D.M., and Thompson E. Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates. Virology 306 (2003) 181-195
14. Hooper J.W., Thompson E., Wilhelmsen C., Zimmerman M., Ichou M.A., Steffen S.E., Schmaljohn C.S., Schmaljohn A.L., and Jahrling P.B. Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox. J. Virol. 78 (2004) 4433-4443
15. Hooper J.W., Golden J.W., Ferro A.M., and King A.D. Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge. Vaccine 25 (2007) 1814-1823
16. Hsiao J.C., Chung C.S., and Chang W. Vaccinia virus envelope D8L protein binds to cell surface chondroitin sulfate and mediates the adsorption of intracellular mature virions to cells. J. Virol. 73 (1999) 8750-8761
17. Huang, G.M., Wei, C.K., 2004. Reports on misbirth of pregnant goats after live attenuated goatpox vaccinations. Guangxi Journal of Husbandry and Veterinary Medicine 20, 214-215. (in Chinese).
18. Ichihashi Y., and Oie M. Neutralizing epitope on penetration protein of vaccinia virus. Virology 220 (1996) 491-494
19. Khatri K., Goyal A.K., Gupta P.N., Mishra N., Mehta A., and Vyas S.P. Surface modified liposomes for nasal delivery of DNA vaccine. Vaccine 26 (2008) 2225-2233
20. Kitching R.P. Vaccines for lumpy skin disease, sheep pox and goat pox. Dev. Biol. (Basel) 114 (2003) 161-167
21. Kitching R.P. Sheeppox and goatpox. In: Coetzer J.A.W., and Tustin R.C. (Eds). Infectious Diseases of Livestock (2004), Oxford University Press 1277-1281
22. Kitching, R.P., Carn, V.M., 2004. Sheep pox and goat pox. Office International des Epizooties Manual of Diagnostic Tests and Vaccines for Terrestrial Animals (mammals, birds and bees). OIE, Paris, pp. 211-220.
23. Kitching R.P., Hammond J.M., and Taylor W.P. A single vaccine for the control of capripox infection in sheep and goats. Res. Vet. Sci. 42 (1987) 53-60
24. Li, H.C., Gao, H.F., Yao, J., 2005. Study on inactivated vaccine against goatpox. Yunnan Journal of Husbandry and Veterinary Medicine (3), 5-6. (in Chinese).
25. Lin C.L., Chung C.S., Heine H.G., and Chang W. Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivo. J. Virol. 74 (2000) 3353-3365
26. Mattion N.M., Harnish E.C., Crowley J.C., and Reilly P.A. Foot-and-mouth disease virus 2A protease mediates cleavage in attenuated Sabin 3 poliovirus vectors engineered for delivery of foreign antigens. J. Virol. 70 (1996) 8124-8127
27. Moss B. Poxviridae: the viruses and their replication. In: Knipe D.M., and Howley P.M. (Eds). Fields Virology. 4th ed. vol. 2 (2001), Lippincott Williams & Wilkins, Philadelphia, Pa 2849-2883
28. Moss B. Poxvirus entry and membrane fusion. Virology 344 (2006) 48-54
29. Pulford D.J., Gates A., Bridge S.H., Robinson J.H., and Ulaeto D. Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB/c mice from a lethal intranasal poxvirus challenge. Vaccine 22 (2004) 3358-3366
30. Rodriguez J.F., Janeczko R., and Esteban M. Isolation and characterization of neutralizing monoclonal antibodies to vaccinia virus. J. Virol. 56 (1985) 482-488
31. Sakhatskyy P., Wang S., Chou T.H., and Lu S. Immunogenicity and protection efficacy of monovalent and polyvalent poxvirus vaccines that include the D8 antigen. Virology 355 (2006) 164-174
32. Szymczak A.L., Workman C.J., Wang Y., Vignali K.M., Dilioglou S., Vanin E.F., and Vignali D.A. Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector. Nat. Biotechnol. 22 (2004) 589-594
33. Thornburg N.J., Rayb C.A., Colliera M.L., Liao H.X., Pickup D.J., and Johnston R.E. Vaccination with Venezuelan equine encephalitis replicons encoding cowpox virus structural proteins protects mice from intranasal cowpox virus challenge. Virology 362 (2007) 441-452
34. Wolffe E.J., Vijaya S., and Moss B. A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies. Virology 211 (1995) 53-63
35. Zhao, L.P., Wei, X.F., Chen, J.L., 2005. Immunoprotection experiments on inactivated vaccine against goatpox. Chinese Journal of Veterinary Drugs 39, 21-23. (in Chinese).